Author: kktan
SMRT – DBSV
Lower final DPS
• 4Q12 core results within expectations
• Final DPS was lower at 5.7 Scts (4Q11: 6.75 Scts)
• Maintain Fully Valued and S$1.50 TP
Highlights
4Q12 core profit was within expectations. Net profit dropped by 59% y-o-y to S$13.9m, while revenue grew by 12% to S$274.8m on higher ridership, taxis, rental and advertising revenues. The drop in profits arose from impairment of goodwill of its buses amounting to S$21.7m. Excluding this, 4Q profit would have increased by c.5% y-o-y, helped by a significantly higher contribution of S$2.2m from its associate (4Q11: S$0.1m). EBIT impacted by higher costs. EBIT (excl. goodwill impairment) fell 5% y-o-y to S$39.4m while margins dropped by 2.5ppts to 14.4% (3Q11: 16.9%). EBIT from train operations, largest contributor to the company, fell 22% y-o-y to S$19.9m, but this was partially helped by stronger contribution from the rental (S$16.4m, +14% y-o-y) and advertising (S$5.1m, +26% y-o-y) segments. In 4Q12, the major cost items that led to a drop in EBIT were electricity and diesel costs (S$42.4m, +37%), repair & maintenance (S$24.1m, +13%) and other operating expenses (S$53.1m, +15%).
Our View
A challenging time for rail. The series of breakdowns since last Dec has brought unprecedented negative focus on its rail operations. Not unexpectedly, the company will step up on its maintenance programme to take into account the aging of the system and to meet increased train runs. It recently announced an upgrading and renewal capex programme that would cost c.S$900m. Discussions with LTA regarding the cost sharing arrangements are ongoing.
Final DPS cut to 5.7 Scts could be the final straw. The challenges faced may have led to a lower final DPS of 5.7 Scts. This, in our view, could trigger a de-rating risk we mentioned in an earlier report on 18 Jan 2012 (“Disembark and move on”). We believe chances are high that its Board of Directors may no longer indicate that it would “endeavour to maintain or increase payout in terms of cents per share”. This, in our view, could be a final straw, particularly for those holding out for stable or higher dividends.
Recommendation
Maintain Fully Valued and S$1.50 TP. With valuations at 18.3x FY13F PE on projected lackluster growth going forward, we believe this counter is pricey. As such, we maintain our Fully Valued recommendation, with a TP of S$1.50, based on blended DCF/PE valuation.
SingTel – BT
Optus to slash 750 jobs for greater efficiencies
Most of the affected are managers and operations, support, back-office staff
SINGAPORE Telecommunications' Australian unit, Optus, will lay off 750 people, slashing almost 8 per cent of its workforce in a restructuring exercise.
In a statement yesterday, Optus said that the new structure is designed to drive greater efficiencies and give customers a stronger voice.
The retrenchments will mean slashing one out of every 12 Optus jobs. At end-2011, Optus employed about 9,700 people.
Telcos around the world have been rationalising their operations. In December, Optus's Australian rival, Telstra, cut 280 jobs.
SingTel – BT
Bharti's profit falls for 9th straight quarter
Bharti Airtel, India's biggest mobile-phone carrier by subscribers, reported its ninth straight quarterly profit decline, hurt by intense price competition, higher interest costs and foreign-exchange fluctuation losses.
The company, controlled by billionaire Sunil Mittal, has lost market share in the past year to smaller rivals in the country's fiercely competitive mobile market, where carriers operate on wafer-thin margins with cheap voice calls accounting for a bulk of revenue.
Mobile data, which offers higher margins, is at a nascent stage in India, and the takeoff of premium third-generation data services has been slower than what the industry had initially expected in a price-sensitive market.
Cellular operators, including Vodafone's local unit, have also been hit by fresh uncertainty in recent months after a court ordered cancellation of all mobile-phone permits awarded in a scandal-tainted sale in 2008.
SMRT – CIMB
Watch out for falling dividends
SMRT faces intensifying headwinds from an ongoing inquiry into its service disruptions. Asset renewal will call for higher capex, while mandates for more stringent repairs and maintenance will elevate its cost structure permanently, eating into profits.
FY12 core misses expectations at 85% of our FY12 and consensus due to goodwill impairment for its bus business. We cut our FY13-14 EPS by 7-8% to incorporate higher opex. Our DCF target (WACC: 6.6%) falls accordingly. Maintain Underperform.
Cash cow no more
What surprised us was a reduction in dividends this quarter, reaffirming our suspicion that SMRT will need to lower its payouts. FY12 dividends totalled 7.45cts, below our 8.5ct forecast, which was culled from management’s earlier guidance of maintaining last year’s absolute payout. We have pre-emptively cut our payout assumptions to 60% of PATMI, lowering forward yields to less than 4%.
With a planned hike in capex for fleet expansion and asset renewal, SMRT could slip into net debt in FY13. Capex will be funded by its MTN programme and debt.
Cost pressure persists
Cashflow strains aside, SMRT continued to contend with margin erosion in 4Q12. Higher repair/maintenance costs and costlier energy erased the benefits of revenue growth from higher ridership. A S$21.7m goodwill impairment for its bus business further ate into profits, causing a 10.4%-pt slump in EBIT margins. We expect a structural increase in SMRT’s cost structure from stricter repair and maintenance mandates.
Poor prospects
Plagued by margin erosion and cashflow strains, we see no reason to own this stock. Further, dividend yields are no longer attractive. Switch to ComfortDelGro for exposure to Singapore’s land transport sector.
RafflesMed – BT
Raffles Med posts 11% gain in Q1 profits
Raffles Medical Group posted net profit of S$11.6 million in the first quarter of 2012, an increase of 10.9 per cent from the same period last year.
The Group said that the increase was due to an overall improved operating performance driven by higher patient load and patient acuity.
As at 31 Mar, the Group had a healthy cash position of S$61.1 million.
Revenue rose 13.2 per cent to S$72.9 million from S$64.4 million last year.